Further evidence supporting the utility of ECT for people with cognitive impairment

The high efficacy and clinical utility of electroconvulsive therapy (ECT) for people with severe or difficult to treat illness is undisputed. While in western countries, ECT is typically used for the treatment of depression, recent evidence from Asian countries has further indicated high efficacy for the treatment of schizophreniform disorders (1). Neuropsychiatric disorders indicated for ECT, including depression and schizophrenia, are frequently associated with cognitive impairment, which can raise concerns during the treatment decision making process.

You may also like...

Enable Notifications    OK No thanks